NEUROTOXICITY RESEARCH is a premier journal published by SPRINGER, focusing on the critical and evolving field of neurotoxicology. With an ISSN of 1029-8428 and an E-ISSN of 1476-3524, this journal serves as a vital platform for researchers, professionals, and students dedicated to understanding the impact of toxic substances on nervous system health. Established in 1999, NEUROTOXICITY RESEARCH has consistently contributed significant findings and discussions that influence both theoretical and applied neuroscience. The journal's impressive Q2 ranking in both Neuroscience (miscellaneous) and Toxicology categories, alongside its strong percentile rankings in Scopus, underscores its relevance and quality in the academic community. While this journal is not open access, it remains a critical resource for those seeking interdisciplinary insights into the mechanisms of neurotoxicity. The objective of NEUROTOXICITY RESEARCH is to elucidate the intricate interactions between environmental and chemical agents and their neurotoxic effects, guiding future research and policies aimed at safeguarding neurological health. Based in the United States at ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY 10004, this journal is committed to advancing the understanding of neurotoxic mechanisms and fostering collaborative efforts within the scientific community.

Current Research in Toxicology is a pioneering journal published by ELSEVIER that serves as a vital platform for disseminating cutting-edge research in the field of toxicology, spanning from biological impacts to pharmacological applications. With an ISSN of 2666-027X and an impressive Q2 ranking in key categories such as Applied Microbiology and Biotechnology, Health, Toxicology and Mutagenesis, and Toxicology, this journal underscores its commitment to high-quality research and significant contributions to the scientific community. Based in the Netherlands, Current Research in Toxicology aims to bridge the gap between academia and industry by providing rigorously peer-reviewed articles that cover a wide array of topics including novel methodologies, regulatory challenges, and emerging trends within the domain. The journal is accessible through various platforms, making it essential for researchers, professionals, and students eager to stay updated on the latest findings and advancements in toxicology. With a comprehensive focus on integrating theory with practical application, this journal is poised to influence future studies and policies in health and environmental science.

Review Journal of Autism and Developmental Disorders, published by Springer Heidelberg, stands as a leading platform for the dissemination of groundbreaking research in the realm of autism and developmental disorders. With an ISSN of 2195-7177 and an E-ISSN of 2195-7185, this journal not only showcases high-quality research but also emphasizes the crucial intersections between behavioral neuroscience, cognitive neuroscience, developmental neuroscience, and psychiatry. Notably, the journal has achieved a prestigious Q1 ranking across these categories, reflecting its impact and relevance; it ranks 10th in behavioral neuroscience and 5th in developmental neuroscience within Scopus metrics. Spanning from 2014 to 2024, the journal is dedicated to fostering a deeper understanding of autism spectrum disorders and related conditions, making it indispensable for researchers, clinicians, and students alike. While it operates under a traditional access model, the quality of the peer-reviewed articles ensures that it remains a valuable resource in the academic community.

Welcome to the JOURNAL OF COGNITIVE NEUROSCIENCE, a premier publication in the field of cognitive neuroscience, published by the esteemed MIT PRESS. Since its inception in 1989, this journal has been at the forefront of advancing our understanding of the neural mechanisms underlying cognitive processes, boasting an impressive convergence period through 2024. With its Q1 ranking in the 2023 cognitive neuroscience category, it stands out among 115 peers, indicating its critical role in shaping contemporary research. The journal offers a comprehensive array of research articles, reviews, and methodologies aimed at researchers, professionals, and students alike, facilitating the exploration of complex cognitive functions. While not an open-access journal, it provides essential insights and significant contributions to the neuroscience community, making it an invaluable resource for anyone keen on delving into the intricacies of the human brain.

Environmental Health Perspectives (EHP) is a premier open-access journal published by the U.S. Department of Health and Human Services, Public Health Science, dedicated to publishing rigorous and impactful research in the field of environmental health. Since its inception in 1972, EHP has become a leading platform for disseminating knowledge on the interactions between the environment and human health, making significant contributions to the fields of toxicology and public health. With an impressive impact factor and a Q1 ranking in both Health, Toxicology and Mutagenesis and Public Health, Environmental and Occupational Health categories, EHP ranks among the top journals globally, reflecting its high citation and visibility within the academic community. Researchers, professionals, and students alike will find a wealth of vital information within its pages, as EHP covers a wide array of topics related to environmental exposures, health outcomes, and policy implications. Furthermore, EHP engages with a global audience through its commitment to open access, ensuring that critical research is available to all, enhancing the collective understanding of environmental health issues since 1972.

Developmental Cognitive Neuroscience is a leading interdisciplinary journal published by ELSEVIER SCI LTD, dedicated to advancing the field of cognitive neuroscience with a specific focus on the developmental aspects of brain function and behavior. Since its inception in 2011, this Open Access journal has continued to thrive, gaining significant recognition with a remarkable impact factor that places it in the Q1 category of cognitive neuroscience, ranking 22nd out of 115 in Scopus. This enhances its visibility and accessibility to a global audience, including researchers, clinicians, and students keen on exploring the intricate relationship between cognitive development and neurological processes. The journal embraces a wide array of topics, from the impact of early life experiences on cognitive outcomes to neurodevelopmental disorders, fostering an enriching platform for disseminating high-quality research and innovative findings. As it progresses towards 2024, Developmental Cognitive Neuroscience remains pivotal in shaping future research and understanding in the field.

ZHURNAL VYSSHEI NERVNOI DEYATELNOSTI IMENI I P PAVLOVA is a prominent academic journal dedicated to the fields of neuroscience and medicine, published by MEZHDUNARODNAYA KNIGA. Since its inception in 1951, this journal has served as a vital platform for disseminating innovative research and findings in the study of nervous activity and complex neural mechanisms. With its ISSN 0044-4677, it provides essential insights that cater to both seasoned researchers and emerging scholars alike. Although currently categorized within the Q4 tier in both the Medicine and Neuroscience fields, the journal actively contributes to advancing knowledge and understanding in these critical areas. The scope of the journal encompasses a broad range of topics pertinent to general neuroscience, making it an invaluable resource for professionals seeking to stay abreast of developments in this dynamic discipline. Researchers and students are encouraged to explore its extensive archives and engage with the diverse perspectives presented throughout its issues.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.

Frontiers in Integrative Neuroscience, published by FRONTIERS MEDIA SA, is an esteemed open-access journal dedicated to advancing our understanding of the intricate workings of the nervous system. Since its inception in 2007, this journal has become a key resource for researchers and professionals in the field, covering a wide range of topics including cellular and molecular neuroscience, cognitive neuroscience, and sensory systems. With a reputation bolstered by its open-access model, Frontiers in Integrative Neuroscience aims to promote expedient dissemination of high-quality research, ensuring that all findings are readily accessible to the scientific community and beyond. The journal has achieved a commendable recognition, ranking in the upper tiers of its respective categories according to Scopus, with a Q2 ranking in both cognitive neuroscience and sensory systems, and a Q3 ranking in cellular and molecular neuroscience. Based in Switzerland, it continues to be a pivotal platform for innovative research that shapes our understanding of neural dynamics, encouraging collaboration and knowledge exchange among scholars worldwide.

GENES BRAIN AND BEHAVIOR is a leading journal published by Wiley that focuses on the intricate interplay between genetic factors and behavioral neuroscience. With a robust ISSN of 1601-1848 and an E-ISSN of 1601-183X, this journal serves as a premier platform for innovative research that spans across multiple fields including genetics, neurology, and behavioral neuroscience. Recognized for its significant impact with a 2023 categorization of Q1 in Behavioral Neuroscience and Q2 in both Genetics and Neurology, GENES BRAIN AND BEHAVIOR asserts itself as an influential resource for scholars, practitioners, and students alike, facilitating the advancement of knowledge in these dynamic areas. Its Scopus rankings underscore its prominence—ranking #18 in Behavioral Neuroscience and #45 in Neurology, placing it in the top percentiles among its peers. Although not an open-access journal, the rigorous peer-review process ensures high-quality publications, pivotal for those pursuing cutting-edge research and applications. With a history of convergence from 2002 to 2024, this journal continues to foster academic dialogue and discovery in the ever-evolving landscape of brain and behavioral studies.